These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effective and well tolerated treatment with melphalan and dexamethasone for primary systemic AL amyloidosis with cardiac involvement. YOSHIZAWA S; AKAHANE D; FUJIMOTO H; GOTOH M; KIGUCHI T; TAUCHI T; OHYASHIKI K Rinsho Ketsueki; 2009 Nov; 50(11):1647-51. PubMed ID: 20009442 [TBL] [Abstract][Full Text] [Related]
27. [Amyloidosis in a mixed pattern. Sensitivity to colchicine and melphalan]. Frustaci A; Gentiloni N; Feoli F Minerva Med; 1981 Apr; 72(15):957-60. PubMed ID: 6784038 [TBL] [Abstract][Full Text] [Related]
28. The systemic amyloidoses. Mahmoud S N Engl J Med; 1998 Jan; 338(4):264; author reply 264-5. PubMed ID: 9441243 [No Abstract] [Full Text] [Related]
29. Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis. McMahan ZH; Sailors JL; Toto R; Olsen NJ J Clin Rheumatol; 2010 Jan; 16(1):22-5. PubMed ID: 20051751 [TBL] [Abstract][Full Text] [Related]
30. [Systemic ALlambda amyloidosis associated with vascular fragility]. Laimer M; Kaindl K; Emberger M; Hawranek T; Lanschützer CM; Bauer JW; Linke RP; Mlineritsch B; Hintner H J Dtsch Dermatol Ges; 2004 Nov; 2(11):934-9. PubMed ID: 16281613 [TBL] [Abstract][Full Text] [Related]
33. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion. Breems DA; Sonneveld P; de Man RA; Leebeek FW Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236 [TBL] [Abstract][Full Text] [Related]
34. Bullous lesions of the vulvar region revealing both AL amyloidosis and vulvar carcinoma. Van De Nieuwenhof HP; Croockewit AJ; Van Der Avoort IA; Bekkers RL; De Hullu JA Amyloid; 2008 Sep; 15(3):210-2. PubMed ID: 18925460 [TBL] [Abstract][Full Text] [Related]
35. Ten years' experience of an amyloid clinic--a clinicopathological survey. Browning MJ; Banks RA; Tribe CR; Hollingworth P; Kingswood C; Mackenzie JC; Bacon PA Q J Med; 1985 Mar; 54(215):213-27. PubMed ID: 3991877 [TBL] [Abstract][Full Text] [Related]
36. The many guises of amyloidosis. Clinical presentations and disease associations. Vogelgesang SA; Klipple GL Postgrad Med; 1994 Oct; 96(5):119-22, 126-7. PubMed ID: 7937410 [TBL] [Abstract][Full Text] [Related]
38. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190 [TBL] [Abstract][Full Text] [Related]
39. Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis. Dispenzieri A; Lacy MQ; Rajkumar SV; Geyer SM; Witzig TE; Fonseca R; Lust JA; Greipp PR; Kyle RA; Gertz MA Amyloid; 2003 Dec; 10(4):257-61. PubMed ID: 14986485 [TBL] [Abstract][Full Text] [Related]
40. From molecular mechanisms toward the cure of systemic amyloidoses. Abstracts of the XII International Symposium on Amyloidosis. April 18-21, 2010. Rome, Italy. Amyloid; 2010 Apr; 17 Suppl 1():38-207. PubMed ID: 20350066 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]